ImmunoForge Co.
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $19M
Investors
- 9
About ImmunoForge Co.
, Ltd. operates as a pharmaceuticals company, specializes in developing novel drugs for rare diseases of the musculoskeletal system, and is expanding and diversifying clinical and non-clinical pipelines. The CEO of the company, Ki-ho Jang, was the general manager of Bio division, Ahngook Pharmaceutical. The company has cooperated with Phase Bio, Syneos Health, KBIO Health and other enterprises. The pipelines of the company are specialized for musculoskeletal diseases. The pipelines include PF1801, PF1802, PF1803 and PF1601. The products offered by the company can be used to cure duchenne muscular dystrophy, becker muscular dystrophy, polymyositis, ALS and other diseases.
Who invested in ImmunoForge Co.
9 investors across 2 rounds
See all investors in ImmunoForge Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmunoForge Co.
Who invested in ImmunoForge Co.?
ImmunoForge Co. has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmunoForge Co. raised?
ImmunoForge Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmunoForge Co. last raise money?
ImmunoForge Co.'s most recent round on record is a Series B, in Sep 2021.
What does ImmunoForge Co. do?
ImmunoForge Co. is a biotechnology company.
Where is ImmunoForge Co. headquartered?
ImmunoForge Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like ImmunoForge Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ImmunoForge Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ImmunoForge Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.